Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1766861019 | Hydrochlorothiazide + methyldopa (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 1778417014 | Hydrochlorothiazide + methyldopa | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3490632013 | Product containing hydrochlorothiazide and methyldopa (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3494826012 | Product containing hydrochlorothiazide and methyldopa | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3666920017 | Hydrochlorothiazide and methyldopa product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3715159017 | Hydrochlorothiazide- and methyldopa-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hydrochlorothiazide- and methyldopa-containing product | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
| Hydrochlorothiazide- and methyldopa-containing product | Is a | Methyldopa-containing product | true | Inferred relationship | Some | ||
| Hydrochlorothiazide- and methyldopa-containing product | Is a | Hydrochlorothiazide-containing product | true | Inferred relationship | Some | ||
| Hydrochlorothiazide- and methyldopa-containing product | Has active ingredient | Hydrochlorothiazide | true | Inferred relationship | Some | 2 | |
| Hydrochlorothiazide- and methyldopa-containing product | Has active ingredient | Methyldopa | true | Inferred relationship | Some | 1 | |
| Hydrochlorothiazide- and methyldopa-containing product | Has active ingredient | Centrally acting antihypertensive agent | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hydrochlorothiazide- and methyldopa-containing product in oral dose form | Is a | True | Hydrochlorothiazide- and methyldopa-containing product | Inferred relationship | Some | |
| Hydrochlorothiazide and methyldopa only product | Is a | True | Hydrochlorothiazide- and methyldopa-containing product | Inferred relationship | Some | |
| Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet | Is a | False | Hydrochlorothiazide- and methyldopa-containing product | Inferred relationship | Some | |
| Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet | Is a | False | Hydrochlorothiazide- and methyldopa-containing product | Inferred relationship | Some | |
| Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet | Is a | False | Hydrochlorothiazide- and methyldopa-containing product | Inferred relationship | Some | |
| Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet | Is a | False | Hydrochlorothiazide- and methyldopa-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR